Brian Sils

Brian Sils
Brian Sils is the research associate at the National Pharmaceutical Council (NPC). In this role, he supports NPC’s senior research staff on a variety of initiatives related to the essential role of biopharmaceuticals in the health care delivery system. He joined NPC in 2020. Before coming to NPC, Mr. Sils worked in Tokyo as a pharmaceutical communications trainer at International Education Services, conducting communications seminars in pharmaceutical companies across Japan. Prior to living in Japan, he served as a health care consultant and senior analyst at the Advis Group outside of Chicago, IL, where he was in charge of delivering …
Brian Sils is the research associate at the National Pharmaceutical Council (NPC). In this role, he supports NPC’s senior research staff on a variety of initiatives related to the essential role of biopharmaceuticals in the health care delivery system. He joined NPC in 2020.

Before coming to NPC, Mr. Sils worked in Tokyo as a pharmaceutical communications trainer at International Education Services, conducting communications seminars in pharmaceutical companies across Japan. Prior to living in Japan, he served as a health care consultant and senior analyst at the Advis Group outside of Chicago, IL, where he was in charge of delivering high-quality financial, operational and feasibility analyses for health care providers. Previously, he also spent time in the lab as a laboratory research technician at the University of Louisville Department of Pharmacology and Toxicology in Louisville, KY.

Mr. Sils holds a Master of Public Policy degree from the University of Chicago Harris School of Public Policy, and a Bachelor of Science degree in cell/molecular biology and history from Tulane University in New Orleans, LA. He also has published several research papers and articles about global health, clinical trials and cell biology in Japan and the United States as well as having served as an editor for academic research in the biological and social sciences.
See more

Articles: Brian Sils

Accumulating Barriers to Care: Double Jeopardy for US Patients

USA / Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for medicines could hurt them financially, exacerbating what is already a challenging time in the midst of the COVID-19 pandemic.   The pandemic has been a challenging time for patients, many of…

See more